Ferroptosis-based Nano Delivery Systems Targeted Therapy for Colorectal Cancer: Insights and Future Perspectives
Overview
Affiliations
There are limited options for patients who develop liver metastasis from colorectal cancer (CRC), the leading cause of cancer-related mortality worldwide. Emerging evidence has provided insights into iron deficiency and excess in CRC. Ferroptosis is an iron-dependent form of programmed cell death characterized by aberrant iron and lipid metabolism, which play crucial roles in tumorigenesis, tumor progression, and treatment options. A better understanding of the underlying molecular mechanism of ferroptosis has shed light on the current findings of ferroptosis-based nanodrug targeting strategies, such as driving ferroptosis in tumor cells and the tumor microenvironment, emerging combination therapy and against multidrug resistance. Furthermore, this review highlights the challenge and perspective of a ferroptosis-driven nanodrug delivery system for CRC-targeted therapy.
Nonviral targeted mRNA delivery: principles, progresses, and challenges.
He X, Li G, Huang L, Shi H, Zhong S, Zhao S MedComm (2020). 2025; 6(1):e70035.
PMID: 39760110 PMC: 11695212. DOI: 10.1002/mco2.70035.
Wu Y, Shang J, Zhang X, Li N J Nanobiotechnology. 2024; 22(1):783.
PMID: 39702277 PMC: 11657939. DOI: 10.1186/s12951-024-02940-4.
Cao S, Wei Y, Yue Y, Wang D, Yang J, Xiong A Front Pharmacol. 2024; 15:1477938.
PMID: 39386034 PMC: 11461269. DOI: 10.3389/fphar.2024.1477938.
Shu Y, Lao B, Qiu Y World J Gastrointest Oncol. 2024; 16(6):2335-2349.
PMID: 38994128 PMC: 11236230. DOI: 10.4251/wjgo.v16.i6.2335.
Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.
Sheikh A, Kesharwani P, Almalki W, Salman Almujri S, Dai L, Chen Z Nanomicro Lett. 2024; 16(1):188.
PMID: 38698113 PMC: 11065855. DOI: 10.1007/s40820-024-01399-0.